Drug Profile
PPV 06
Alternative Names: Anti-IL-6 vaccine - Peptinov; PPV-06Latest Information Update: 28 Mar 2024
Price :
$50
*
At a glance
- Originator Peptinov
- Class Anti-inflammatories; Antirheumatics; Peptide vaccines
- Mechanism of Action Interleukin 6 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Multiple sclerosis; Osteoarthritis
Most Recent Events
- 28 Mar 2024 No recent reports of development identified for phase-I development in Osteoarthritis in France (SC, Injection)
- 18 Feb 2021 Phase-I clinical trials in Osteoarthritis in France (SC) (NCT04447898)
- 28 Aug 2020 No recent reports of development identified for preclinical development in Multiple-sclerosis in France (SC, Injection)